The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kendall Keith J since 1.
The trader's CIK number is 1406834.
At the time of the last reporting, Kendall Keith J was the CEO and President of Aquestive Therapeutics, Inc.. (stock ticker symbol AQST).
Also see all insider trading activities at Aquestive Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | AQST | 0 | $0 | 50,000 | $255,300 | 30,135 | $0 |
| 2019 | AQST | 8,000 | $30,991 | 0 | $0 | 59,604 | $0 |
| 2019 | AQST | 0 | $0 | 0 | $0 | 5,593 | $0 |
| 2018 | AQST | 8,950 | $90,195 | 0 | $0 | 29,473 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-06-30 | AQST | Option Ex | 333 | .00 | 0 |
| 2020-06-04 | AQST | Sale | 50,000 | 5.11 | 255,300 |
| 2020-05-31 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2020-03-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2020-02-29 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-11-30 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-09-30 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-08-31 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-08-14 | AQST | Buy | 2,000 | 3.67 | 7,346 |
| 2019-08-09 | AQST | Buy | 5,000 | 3.92 | 19,600 |
| 2019-08-13 | AQST | Buy | 1,000 | 4.04 | 4,045 |
| 2019-06-30 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-05-31 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-03-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-02-28 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2018-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2018-11-30 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2018-11-27 | AQST | Buy | 1,000 | 9.87 | 9,870 |
| 2018-11-23 | AQST | Buy | 1,950 | 9.90 | 19,305 |
| 2018-11-21 | AQST | Buy | 6,000 | 10.17 | 61,020 |
| 2018-09-30 | AQST | Option Ex | 329 | .00 | 0 |
| 2018-08-31 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kendall Keith J (CEO and President of Aquestive Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.